PETS - Why PetMed Express Was a Dog of a Stock This Week
While animal healthcare specialist PetMed Express (NASDAQ: PETS) advertises itself as "your trusted pet expert," the stock market wasn't trusting it as a solid investment this week. According to data compiled by S&P Global Market Intelligence , the company's shares fell by 13% for the week, largely due to its lackluster quarterly results.
In the third quarter of its fiscal 2023, PetMed Express booked $58.9 million in net sales, a slight drop from the $60.7 million it made in the same quarter of the previous fiscal year. On the bottom line, the company landed in the red, although not deeply -- its GAAP net loss was $19,000. However, this compared unfavorably to its nearly $4.3 million profit in the prior-year period.
Neither line item met analysts' estimates. On average, the prognosticators following Pet Med Express's stock were expecting $62.9 million on the top line, and a net income figure of $0.21 per share.
For further details see:
Why PetMed Express Was a Dog of a Stock This Week